← Back
Data updated: Mar 10, 2026
HQ SPECLT PHARMA
Infectious DiseaseDermatologyGastroenterology
HQ SPECLT PHARMA is a generic drug manufacturer focused on Infectious Disease, Dermatology, Gastroenterology.
1992
Since
4
Drugs
-
Trials
44
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-01-30
Labeling
AMPICILLIN AND SULBACTAM 2026-01-27
Labeling
AMPICILLIN AND SULBACTAM 2026-01-19
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 50%
2 drugs
Dermatology 25%
1 drugs
Gastroenterology 25%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Pfizer big-pharma
Infectious Disease, Dermatology, Gastroenterology
APOTHECON specialty
Infectious Disease, Dermatology, Gastroenterology
Baxter specialty
Infectious Disease, Dermatology
CASPER PHARMA LLC big-pharma
Infectious Disease, Gastroenterology, Dermatology
B BRAUN specialty
Infectious Disease, Dermatology
Active (2)
Discontinued (2)
Company Info
- First Approval
- 1992-07-14
- Latest
- 2026-01-19
- Applications
- 6